MYLK3: Myosin Light Chain Kinase 3

A cardiac-specific kinase regulating myocardial contractility and sarcomere organization

Gene Information Card

Symbol MYLK3
Full Name myosin light chain kinase 3
Gene Type protein-coding
Chromosomal Location 16q11.2
NCBI Gene ID 91807 ncbi.nlm.nih.gov/gene/91807
Ensembl ID ENSG00000103044
UniProt ID Q32MK0
OMIM ID 613543
HGNC ID 29824
Aliases MLCK3, caMLCK, MLCK, cardiac MLCK

Description

MYLK3 encodes a cardiac-specific myosin light chain kinase that phosphorylates the regulatory light chain of myosin (MYL2) in heart muscle. This phosphorylation is essential for sarcomere assembly, myofibril organization, and normal cardiac contractility. MYLK3 is predominantly expressed in the heart and plays a critical role in cardiomyocyte differentiation and function.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Dilated cardiomyopathy (DCM) Loss-of-function mutations impair MYL2 phosphorylation, disrupting sarcomere assembly and contractile force generation. ClinVar, OMIM
Hypertrophic cardiomyopathy (HCM) Missense variants may alter kinase activity or substrate binding, leading to aberrant myosin regulation and hypertrophy. ClinVar, OMIM
Left ventricular noncompaction (LVNC) MYLK3 mutations associated with reduced kinase activity impair myocardial compaction during development. ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 58.2 High
Skeletal muscle 2.1 Low
Brain 0.5 Not detected
Liver 0.3 Not detected
Lung 0.4 Not detected
Cell Line Expression
Cell Line nTPM Notes
Cardiomyocytes (iPSC-derived) 62.8 High expression; essential for sarcomere formation
HeLa 0.2 Not detected
HEK293 0.1 Not detected
HepG2 0.3 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.172C>T (p.Arg58Trp) Missense <0.01% Reduced kinase activity; associated with DCM
c.1045G>A (p.Glu349Lys) Missense <0.01% Impaired MYL2 phosphorylation; HCM risk
c.1234del (p.Leu412fs) Frameshift <0.01% Loss of function; truncation; DCM
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., p.Leu412fs) lead to truncated, non-functional kinase, reducing MYL2 phosphorylation and sarcomere integrity.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in MYLK3.

Dominant Negative (DN)

Missense variants (e.g., p.Arg58Trp) may act dominant-negative by dimerizing with wild-type kinase and impairing overall activity.

Pathways

Cardiac muscle contraction (KEGG: hsa04260)
cGMP-PKG signaling pathway (KEGG: hsa04022)
Regulation of actin cytoskeleton (KEGG: hsa04810)

Protein Summary

MYLK3 (cardiac myosin light chain kinase) is a 100 kDa serine/threonine kinase specifically expressed in cardiac muscle. It phosphorylates the regulatory light chain of myosin (MYL2) at Ser15, a key step for myosin motor function and sarcomere assembly. The protein contains an N-terminal kinase domain, a calmodulin-binding region, and a C-terminal domain involved in localization to the sarcomere. MYLK3 activity is calcium/calmodulin-dependent and essential for maintaining cardiac contractility. Loss-of-function mutations cause dilated cardiomyopathy, while missense variants are linked to hypertrophic cardiomyopathy and left ventricular noncompaction.

Related Products

Product name Cat.No. Species Gene ID
MYLK3 Knockout HEK293 Cell Line EDJ-KQ853 Human 91807 Details Get a Quote
MYLK3 Knockout HeLa Cell Line EDJ-KQ20983 Human 91807 Details Get a Quote
MYLK3 Knockout A-549 Cell Line EDJ-KQ66309 Human 91807 Details Get a Quote
MYLK3 Knockout HCT 116 Cell Line EDJ-KQ74732 Human 91807 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: